Effect of zeranol or melengestrol acetate (MGA) on testicular and antler development and aggression in farmed fallow bucks.
Fifteen yearling fallow bucks were randomly assigned by BW to one of three treatment groups: control (C; n = 5), melengestrol acetate (MGA; n = 5), and zeranol (Z; n = 5), to evaluate effects on testicular development, aggressive behavior, antler growth, sexual activity, ADG, and BW. Zeranol-treated bucks received zeranol ear implants (36 mg) at 90-d intervals, and MGA-treated bucks received MGA in the ration (100 microg x animal(-1) x d(-1)). Bucks grazed ryegrass/Coastal bermudagrass pasture and were supplemented with 3:1 corn/soybean meal at 0.45 kg x animal(-1) x d(-1). Body weights, body condition scores (BCS), blood samples, and testis measurements were obtained at d 0 and at 14-d intervals for 229 d. As bucks reached hard antler (7/15 to 8/25), antlers were harvested and weighed, and ejaculates were collected at 14-d intervals. Aggression was evaluated using 10-min video sessions scoring body blows, avoidance, head pushes, and head bunts. Scrotal circumference (SC) and paired testis volume were affected by a day x treatment interaction (P < 0.01); testes of zeranol-treated bucks were smaller than those of control or MGA-treated bucks. First sperm in the ejaculate tended to be delayed (P < 0.10) in zeranol-treated bucks compared with control and MGA-treated bucks. Melengestrol acetate-treated bucks had a maximum sperm concentration in the ejaculate that was three times (P < 0.05) that of control bucks and nine times (P < 0.05) that of zeranol-treated bucks. Antler weight was the least (P < 0.01) for bucks receiving zeranol and greatest (P < 0.10) for MGA-treated bucks; intermediate values were recorded for the control bucks. Aggressive behavior was delayed (P < 0.05) for zeranol-treated bucks until treatment effects were overcome. Melengestrol acetate-treated bucks had decreased (P < 0.01) aggressive behavior compared with control bucks. Melengestrol acetate-treated bucks had increased (P < 0.05) serum testosterone concentrations compared with control and zeranol-treated bucks. Human chorionic gonadotropin-stimulated peak serum testosterone concentrations for zeranol-treated bucks were delayed (P < 0.01) compared with control and MGA-treated bucks. Although zeranol-treated bucks overcame treatment effects, they were never able to reach testicular measurements or sperm concentrations equal to those of the control or MGA-treated bucks. Zeranol and MGA treatments may have both positive and negative effects that can be utilized when producing slaughter bucks.
Wilson
T W
TW
Texas A&M University Agricultural Research and Extension Center, Overton 75684, USA.
Neuendorff
D A
DA
Lewis
A W
AW
Randel
R D
RD
D000374:Aggression / Q000187:drug effects; D000818:Animals; D000999:Antlers / Q000187:drug effects / Q000254:growth & development; D001522:Behavior, Animal / Q000187:drug effects*; D003670:Deer / Q000254:growth & development / Q000502:physiology* / Q000523:psychology; D004343:Drug Implants; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology*; D008297:Male; D008552:Melengestrol Acetate / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D045167:Progesterone Congeners / Q000494:pharmacology*; D011897:Random Allocation; D012611:Scrotum / Q000033:anatomy & histology / Q000187:drug effects; D012741:Sexual Maturation / Q000187:drug effects; D013076:Sperm Count / Q000662:veterinary; D013737:Testis / Q000187:drug effects / Q000254:growth & development; D013739:Testosterone / Q000097:blood; D015430:Weight Gain / Q000187:drug effects; D015029:Zeranol / Q000494:pharmacology*
D004343:Drug Implants; D004968:Estrogens, Non-Steroidal; D045167:Progesterone Congeners; D013739:Testosterone; D008552:Melengestrol Acetate; D015029:Zeranol